LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of two packages of LORATADINE TABLETS with NSN 6505013770448 at a total price of $40.02. The order was issued on July 14, 2026, with a delivery deadline of July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms obligating the contractor to bear all transportation costs and risks until receipt at the destination. The item is delivered in standard military packaging using traceable means, with parcel post explicitly prohibited; each shipment must be clearly marked with the Transportation Control Number W50YF252480014, shipment number, and bill of lading number to ensure accountability. Inspection and acceptance occur at the delivery point, and payment will be processed by the Defense Finance and Accounting Service through a voucher system using the payment code SL4701 and accounting data BX:97X4930 5CBX 001 2620 S33189. The awardee is certified as a Women-Owned Small Business and affirmed its small business status under FAR Part 19, triggering compliance obligations for subcontracting and potential SBA verification. Contract administration is managed by Lisa Quinn, Contracting Officer, and Shairy M. Cartagena of DLA Troop Support’s Medical Supply Chain Pharm FSA, with no designated COR or COTR named. The procurement, valued at a minimal amount and involving a commercially available pharmaceutical product, reflects standard DLA LPTA practices, with no technical evaluation factors, options, or performance incentives indicated. No explicit contract clauses, attachments, special requirements, or detailed specifications beyond unit-of-issue and delivery instructions were provided in the document, suggesting full reliance on referenced base contract terms and standard military logistics protocols.